Structure Therapeutics · 10 hours ago
Director, Talent Programs & Platforms
Structure Therapeutics is a biotechnology company focused on developing life-changing medicines through advanced drug discovery technology. The Director, Talent Programs & Platforms will build and scale the talent infrastructure to support a diverse workforce in scientific, clinical, and corporate roles, ensuring effective talent acquisition and integration in a competitive environment.
BiotechnologyHealthcarePharmaceuticalHealth CareMedicalProduct Research
Responsibilities
Own the enterprise talent technology roadmap supporting scientific, clinical, GxP, manufacturing, and corporate roles
Serve as business owner for ATS, CRM, onboarding platforms, recruitment marketing tools, assessments, scheduling, and analytics
Ensure platforms support compliance, audit readiness, data integrity, and global scalability
Partner with IT and vendors on integrations, upgrades, and optimization
Lead recruitment marketing strategy for specialized scientific and technical talent (e.g., discovery, translational, clinical, regulatory, CMC)
Own employer brand and employee value proposition in partnership with Marketing and Communications
Oversee career site strategy, scientific storytelling, digital and social campaigns, and talent community engagement
Measure brand strength and campaign effectiveness across priority talent segments
Design and manage enterprise talent programs including early career, postdoctoral and PhD pipelines, internal mobility, referrals, DEI initiatives, and hiring manager enablement
Establish scalable, compliant talent processes aligned with functional and pipeline needs
Drive continuous improvement to support rapid growth and evolving scientific priorities
Design and facilitate enterprise onboarding programs that accelerate productivity, engagement, and cultural integration
Ensure onboarding experiences meet regulatory, compliance, and GxP requirements for scientific and technical roles
Partner with HR, IT, Facilities, EHS, and business leaders to deliver seamless pre-boarding and onboarding experiences
Measure onboarding effectiveness through time-to-productivity, early attrition, and new hire feedback
Continuously improve onboarding programs to support growth, change, and workforce flexibility
Own the enterprise contract and contingent workforce strategy, including scientific contractors, consultants, and clinical resources
Partner with Procurement, Legal, Finance, and Compliance to ensure proper worker classification and regulatory adherence
Oversee VMS platforms, staffing suppliers, and workforce mix analytics
Establish governance to manage cost, risk, and flexibility
Define talent and contingent workforce metrics tied to pipeline milestones, capacity planning, quality outcomes, and onboarding effectiveness
Deliver executive-ready dashboards to inform workforce strategy and investment decisions
Ensure consistent data definitions and reporting across functions and geographies
Lead adoption of new platforms, programs, and processes across scientific and non-scientific teams
Develop training and enablement for recruiters, hiring managers, and business leaders
Manage vendors, budgets, and governance for talent platforms, programs, and onboarding
Qualification
Required
8–12+ years of experience in talent programs, recruiting operations, onboarding, or HR technology
Experience supporting biotech, pharma, or life sciences organizations
Proven ownership of enterprise talent platforms and programs
Strong cross-functional leadership and influence skills
Preferred
Experience in regulated (GxP) environments
Global or multi-site experience
Background supporting rapid growth or pipeline-driven organizations
Benefits
Annual performance incentive bonus
New hire equity
Ongoing performance-based equity
Medical, dental, and vision insurance
401k match
Unlimited PTO
A number of paid holidays including winter shutdown
Company
Structure Therapeutics
Structure Therapeutics specializes in the discovery and development of drugs against a type of targets called GPCR.
Funding
Current Stage
Public CompanyTotal Funding
$1.77BKey Investors
Biotechnology Value FundQiming Venture Partners
2025-12-09Post Ipo Equity· $747.5M
2024-06-05Post Ipo Equity· $547.4M
2023-09-29Post Ipo Equity· $300M
Recent News
2026-02-06
2026-02-04
Company data provided by crunchbase